The Continuing Saga of Hospital Price Transparency and Surprise Billing
This article written by Michael A. Cassidy appeared in the September 2021 Issue of the Allegheny County Medical Society Bulletin.…
Could a Trademark Search Have Saved ‘The Cleveland Indians’ Botched Rebrand?
Judge Rules Against AI as an Inventor in Patent Case
Los Angeles Clippers and Intuit Enter into 23-Year Naming Rights Agreement and Name the New Arena in Inglewood Intuit Dome
Kee Published in New Orleans CityBusiness on Non-Competition Agreements Under Louisiana Law
P.J. Kee, a partner in the Labor & Employment Practice Group and a member of the trade secrets and fair competition team, authored the article “Do’s and Don’ts for Non-Competition Agreements Under Louisiana Law” featured in New Orleans CityBusiness. P.J. provides an outline of La. Rev. Stat. § 23:921, and the courts interpreting it, to better ensure these agreements are enforceable.…
Senate Bill Proposes to Reset PTAB Practices
Key Members of Congress Urge USPTO to Curtail Discretionary Denials of IPR Petitions to Help Lower Drug Costs by Breaking Patent Thickets
Curiosity Killed A Motion to Dismiss: A Biotech Company’s Business Negotiations Turn into a Trade Secrets Fight
Circuit Courts Continue To Limit Preclusive Effect of TTAB Decisions
Tanvex and Biocad announce Phase III results at ESMO Congress
Last week, results of Tanvex’s phase III study on its trastuzumab biosimilar candidate (TX05) were published in connection with the European Society for Medical Oncology’s (ESMO’s) Congress 2021. The study compared the efficacy and safety of TX05 to Herceptin in patients with HER2+ early breast cancer. The poster provides the following conclusions: “The pCR risk ratio was within the predefined equivalence margins, confirming therapeutic equivalence of TX05 and Herceptin. Secondary endpoints including ORR, safety and…